What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
Detlev Boison mainly investigates Adenosine, Adenosine kinase, Neuroscience, Epilepsy and Epileptogenesis.
His Adenosine research is multidisciplinary, incorporating perspectives in Adenosine A1 receptor, Adenosine receptor and Pharmacology.
Detlev Boison studies ADK, a branch of Adenosine kinase.
His Neuroscience research incorporates themes from Long-term potentiation, Adenosine A2A receptor and Glycine transporter 1.
His research in Epilepsy intersects with topics in Stroke, Neuroprotection, Premovement neuronal activity and Traumatic brain injury.
The Epileptogenesis study combines topics in areas such as Status epilepticus and Astrogliosis.
His most cited work include:
- Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice (196 citations)
- Arousal Effect of Caffeine Depends on Adenosine A2A Receptors in the Shell of the Nucleus Accumbens (195 citations)
- A ketogenic diet suppresses seizures in mice through adenosine A1 receptors (193 citations)
What are the main themes of his work throughout his whole career to date?
Detlev Boison mainly focuses on Adenosine, Adenosine kinase, Neuroscience, Epilepsy and ADK.
Detlev Boison has included themes like Adenosine receptor, Epileptogenesis and Pharmacology in his Adenosine study.
As a member of one scientific family, Detlev Boison mostly works in the field of Adenosine kinase, focusing on Neuroprotection and, on occasion, Ischemia.
His Neuroscience research is multidisciplinary, relying on both Glutamatergic and Glycine transporter 1.
His Epilepsy study incorporates themes from Anesthesia, Epigenetics and Traumatic brain injury.
His ADK study integrates concerns from other disciplines, such as Schizophrenia, Gene knockdown, Immunology, Glial fibrillary acidic protein and Molecular biology.
He most often published in these fields:
- Adenosine (64.52%)
- Adenosine kinase (50.32%)
- Neuroscience (50.32%)
What were the highlights of his more recent work (between 2018-2021)?
- Adenosine (64.52%)
- Adenosine kinase (50.32%)
- Epilepsy (37.42%)
In recent papers he was focusing on the following fields of study:
Detlev Boison mostly deals with Adenosine, Adenosine kinase, Epilepsy, ADK and Epigenetics.
His Adenosine research is within the category of Internal medicine.
The various areas that Detlev Boison examines in his Adenosine kinase study include Cancer cell, Cancer research, Adenosine A2A receptor and Cell biology.
Epilepsy is a primary field of his research addressed under Neuroscience.
His studies deal with areas such as Glutamate receptor, Schizophrenia and Respiratory distress as well as ADK.
His study in Epileptogenesis is interdisciplinary in nature, drawing from both Kainic acid, Pharmacology and Hippocampal sclerosis.
Between 2018 and 2021, his most popular works were:
- Adenosine Metabolism: Emerging Concepts for Cancer Therapy. (52 citations)
- Transient use of a systemic adenosine kinase inhibitor attenuates epilepsy development in mice. (14 citations)
- Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies (13 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
His main research concerns Adenosine kinase, Adenosine, Epileptogenesis, Epilepsy and Adenosine receptor.
The study incorporates disciplines such as Dentate gyrus, Forebrain, Cell growth, Cell biology and Neural stem cell in addition to Adenosine kinase.
His work on Kinase expands to the thematically related Adenosine.
His Epileptogenesis research includes themes of Hippocampal sclerosis, Granule cell dispersion, Kainic acid and Astrogliosis.
His Epilepsy study is associated with Neuroscience.
His research on Adenosine receptor often connects related topics like Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
